8,517 articles
Andrea Z. LaCroix
Andrea Z. LaCroix is an American epidemiologist and Distinguished Professor at UC San Diego who led Women's Health Initiative activities and menopause-symptom trials for over 17 years.
Andreas Bernkop‐Schnürch
Andreas Bernkop-Schnürch, also published as A. Bernkop-Schnürch, is an Austrian pharmaceutical technologist, professor at the University of Innsbruck, and inventor of thiolated polymers (thiomers) and charge-converting nanoparticles for mucosal drug delivery.
Andreas du Bois
Andreas du Bois is a German gynecologic oncologist who founded the AGO Study Group in 1993 and led landmark ovarian cancer trials including LION and DESKTOP III.
Andreas E. Kulozik
Andreas E. Kulozik is a German physician-scientist in pediatrics and molecular medicine who has directed pediatric oncology at Heidelberg University Hospital since 2001 and studies nonsense-mediated mRNA decay.
Andreas Engert
Andreas Engert is a German physician-scientist in hematology and oncology at University Hospital Cologne whose German Hodgkin Study Group trials, HD10 and HD18, defined modern PET-adapted therapy for Hodgkin lymphoma.
Andreas Greinacher
Andreas Greinacher is a German physician-scientist in transfusion medicine who headed the department at Universitätsmedizin Greifswald from 1994 to 2024 and identified VITT after COVID-19 vaccination in 2021.
Andreas H. Diacon
Andreas H. Diacon, also published as Andreas Diacon, is a Swiss and South African pulmonologist who led trials establishing bedaquiline and pretomanid for drug-resistant tuberculosis and founded TASK Applied Science in Cape Town.
Andreas Hochhaus
Andreas Hochhaus is a German hematologist-oncologist and director of the Department of Hematology and Oncology at Jena University Hospital, known for transforming chronic myeloid leukemia treatment and monitoring.
Andreas Keller
Andreas Keller is a German bioinformatician and professor of clinical bioinformatics at Saarland University since 2013, known for defining the blood-borne miRNome of human diseases.
Andreas Linkermann
Andreas Linkermann is a German nephrologist and transplantation physician known for research on necroptosis and ferroptosis in acute kidney injury, chair of Nephrology at Heidelberg University since 2024.
Andreas M. Zeiher
Andreas M. Zeiher, born 1955 in Freiburg, is a German cardiologist at Goethe University Frankfurt known for the 2006 REPAIR-AMI trial and the 2018 ODYSSEY OUTCOMES trial.
Andreas Meyer-Lindenberg
Andreas Meyer-Lindenberg is a German psychiatrist and neuroscientist, Medical Director of the Central Institute of Mental Health in Mannheim since 2007, known for imaging genetics of schizophrenia.
Andreas Strasser
Andreas Strasser is an Australian molecular biologist who heads the Blood Cells and Blood Cancer Division at WEHI in Melbourne, studying how defective cell death causes cancer.
Andreas von Deimling
Andreas von Deimling is a German neuropathologist who has chaired neuropathology at Heidelberg University since 2007 and developed IDH1-R132H and BRAF-V600E antibodies underpinning WHO glioma classification.
Andreas Zimmer
Andreas Zimmer (born 1959) is a German pharmacologist and molecular psychiatrist who leads the Institute of Molecular Psychiatry at the University of Bonn and studies cannabinoids in aging.
Andreea Creanga
Andreea A. Creanga is a Romanian-born reproductive and perinatal epidemiologist who led CDC maternal mortality surveillance, won a 2012 Presidential Early Career Award, and directs Maryland's MDMOM program.
Andrei V. Gudkov
Andrei V. Gudkov is a Russian-born molecular biologist and cancer researcher at Roswell Park in Buffalo, New York, known for suppressing p53 to protect normal tissue from therapy side effects.
Andrés Cervantes
Andrés Cervantes is a Spanish medical oncologist, Scientific Director of the INCLIVA institute in Valencia, who researches colorectal cancer and led ESMO as president from 2023 to 2024.
Andrés Hidalgo
Andrés Hidalgo (Andrés Hidalgo Alonso) is a Spanish immunologist known for research reframing neutrophils as a heterogeneous population, and is Professor of Immunobiology at Yale.
Andrew A. Grace
Andrew A. Grace, also published as Andrew Grace, is a British cardiologist and Professor of Experimental Cardiology at Cambridge who developed the subcutaneous implantable defibrillator.
Andrew A. Lane
Andrew A. Lane is an American physician-scientist who treats and studies acute leukemias, leading the Division of Hematologic Neoplasia at Dana-Farber Cancer Institute and its BPDCN Center.
Andrew Bottomley
Andrew Bottomley is a British psychologist and researcher who led the EORTC Quality of Life Department in Brussels for over two decades, setting standards for quality-of-life measurement in cancer trials.
Andrew Bush
Andrew Bush, born 1954, is a British pediatric respiratory physician at Imperial College London and Royal Brompton Hospital, known for work on severe childhood asthma and cystic fibrosis.
Andrew Carr (Australian immunologist)
Andrew Carr is an Australian clinical immunologist at St Vincent's Hospital, Sydney, who first described HIV lipodystrophy and was named a top 10 HIV researcher by Science in 2008.
Andrew Conway Ivy
Andrew Conway Ivy (1893–1978) was an American gastrointestinal physiologist at Northwestern University who helped shape the Nuremberg Code, then championed the discredited cancer drug Krebiozen.
Andrew D. Rule
Andrew D. Rule is a nephrologist and Professor of Medicine at Mayo Clinic in Rochester, Minnesota, known for research on kidney aging, GFR estimation, and living kidney donor outcomes.
Andrew D. Yeoman
Andrew D. Yeoman is a consultant hepatologist at the Gwent Liver Unit, Newport, Wales, and clinical lead of the Wales Liver Plan and the UK Liver Alliance's early detection work.
Andrew E. Arai
Andrew E. Arai is an American cardiologist who led the NIH cardiac MRI research program from 1994 to 2021 and is now a professor at the University of Utah.
Andrew E. Rosenberg
Andrew E. Rosenberg is an American bone and soft tissue pathologist who spent 30 years at Massachusetts General Hospital and Harvard before joining the University of Miami in 2011.
Andrew F. Stewart
Andrew Fyfe Stewart is an American endocrinologist who directs the Diabetes, Obesity and Metabolism Institute at Mount Sinai and develops drugs that regenerate insulin-producing beta cells.